Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 19/11/19981 min de leitura
Danbury Pharmacal, Inc.; Withdrawal of Approval of 61 Abbreviated New Drug Applications
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is withdrawing approval of 61 abbreviated new drug applications (ANDA's). Danbury Pharmacal, Inc., notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →